Increased risk of hyperglycemia of hypoglycemia if changes in physical activity, meal patterns, concomitant medications, renal or hepatic function, insulin regimen, administration site ...

CVS Health's Caremark and Cigna's Express Scripts — of "engaging in anticompetitive and unfair rebating practices that have ...

Doescher: I just want to make sure I get that. Haislmaier: The drug, the list price goes up. Doescher: Yes. The price for my insulin goes up. Haislmaier: And you may be paying more as the patient ...

Then, I compared 14 plans that have the same name across the country ... in the coverage of these drugs, which becomes an important concern for those who need insulin. There are probably 12 ...

This “recombinant insulin” first came on the market in the mid-1980s, under the brand name Humulin. After its release, Humulin quickly replaced traditional sources of insulin. Today, almost all ...

“Although not named in this case, all drug manufacturers should be ... adding that the company has not raised list prices for ...

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

Here's what to know about weight loss drugs such as Wegovy and Zepbound. CR helps you decide whether semaglutide or ...

In particular, the agency argued that the rebate practices of Caremark, Express Scripts, and OptumRx caused the list prices of insulin drugs to be artificially high and limited patients' access to ...

Drug giant Eli Lilly has announced a ... It is also dropping the list price of its non-branded insulin, Lispro, to $25 a vial, effective 1 May. "While the current healthcare system provides ...

Insulin 6x is a single ingredient drug in this case and writing ‘Insulin Tablets’ on the label imitating it as a proprietary name was in violation of the Drugs and Cosmetics Rules, 1945.